Norketotifen for the Treatment of Uncomplicated Influenza-like Illness
Clinical trial NCT04043923 · COMPLETED
Trial details
- NCT number
- NCT04043923
- Sponsor
- Emergo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-21
- Primary completion
- 2020-04-05
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.